
Efoglim MP 1mg/500mg/15mg Tablet
Marketer
Oldmed Healthcare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Efoglim MP 1mg/500mg/15mg Tablet
Metformin/Glimepiride/Pioglitazone 1mg/500mg/15mg tablets offer a combined approach to managing blood glucose. This medication, used alongside diet and exercise, enhances blood sugar regulation in adults with type 2 diabetes. It promotes efficient insulin utilization, leading to reduced blood sugar. Dosage and duration should strictly adhere to your physician's instructions. Ingestion with food is recommended to minimize stomach discomfort. Missed doses should be taken promptly, unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; overdosage can result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol consumption, or skipped meals increases the risk of hypoglycemia. Regular blood sugar monitoring is crucial. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be performed before commencing therapy. Limit alcohol consumption as it may heighten the likelihood of side effects.
Uses of Efoglim MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Efoglim MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Efoglim MP 1mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Efoglim MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Efoglim MP 1mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Efoglim MP 1mg/500mg/15mg Tablet with food.
How Efoglim MP 1mg/500mg/15mg Tablet works:
Efoglim MP tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Efoglim MP 1mg/500mg/15mg tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Using Efoglim MP 1mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Using Efoglim MP 1mg/500mg/15mg tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer of the medication to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Efoglim MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. For individuals with severe kidney disease, this medication is contraindicated. Regular monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Efoglim MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. The use of Efoglim MP 1mg/500mg/15mg tablets is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Efoglim MP 1mg/500mg/15mg Tablet :
Should you forget to take your Efoglim MP 1mg/500mg/15mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Efoglim MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
